Expertise in
8
conditions

Dr. Taizo A. Nakano

Hematology | Oncology
Children's Hospital Colorado
13123 E 16th Ave, 
Aurora, CO 
Accepting New Patients
Expertise in
8
conditions
Children's Hospital Colorado
13123 E 16th Ave, 
Aurora, CO 

Overview

Taizo Nakano is a Hematologist and an Oncologist practicing medicine in Aurora, Colorado.

Dr. Nakano is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Aplastic Anemia, Shwachman-Diamond Syndrome, Anemia, and Immune Thrombocytopenic Purpura (ITP).

He is actively involved in clinical research, co-authoring 46 peer reviewed articles and participating in 5 clinical trials. Dr. Nakano is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Pediatrics in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Rocky Mountain Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

Children's Hospital Colorado
13123 E 16th Ave, Aurora, CO 80045

Additional Areas of Focus

Dr. Nakano has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase II, Open-label, Non-controlled, Intra-patient Dose-escalation Study to Characterize the Pharmacokinetics After Oral Administration of Eltrombopag in Pediatric Patients With Refractory, Relapsed or Treatment Naive Severe Aplastic Anemia or Recurrent Aplastic Anemia
A Phase II, Open-label, Non-controlled, Intra-patient Dose-escalation Study to Characterize the Pharmacokinetics After Oral Administration of Eltrombopag in Pediatric Patients With Refractory, Relapsed or Treatment Naive Severe Aplastic Anemia or Recurrent Aplastic Anemia
Enrollment Status: Completed
Publish Date: August 10, 2026
Intervention Type: Drug
Study Drugs: Eltrombopag, Anti-Thymocyte Globulin, Cyclosporine
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Oral Rilzabrutinib (PRN1008) in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Oral Rilzabrutinib (PRN1008) in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
Enrollment Status: Active_not_recruiting
Publish Date: February 23, 2026
Intervention Type: Drug
Study Drug: Rilzabrutinib
Study Phase: Phase 3
Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Enrollment Status: Completed
Publish Date: June 18, 2025
Intervention Type: Other
Study Phase: Phase 3
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Drug, Procedure, Radiation
Study Phase: Not Applicable
Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
Enrollment Status: Terminated
Publish Date: August 04, 2022
Intervention Type: Drug
Study Drug: VT30
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

46 Total Publications

Terminal Complement Inhibition for Refractory IgA-Mediated Autoimmune Hemolytic Anemia in a Pediatric Heart Transplant Recipient.
Terminal Complement Inhibition for Refractory IgA-Mediated Autoimmune Hemolytic Anemia in a Pediatric Heart Transplant Recipient.
Journal: Pediatric blood & cancer
Published: June 23, 2026
Similar Doctors
Expertise in
13
conditions
Dr. Rajeev Vibhakar
Hematology | Oncology
Expertise in
13
conditions
Dr. Rajeev Vibhakar
Hematology | Oncology
Referral may be required

Children's Hospital Colorado

13123 E 16th Ave, 
Aurora, CO 
 (0.1 miles away)
720-777-1234
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Rajeev Vibhakar is a Hematologist and an Oncologist practicing medicine in Aurora, Colorado. Dr. Vibhakar is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Gliomatosis Cerebri. Dr. Vibhakar is currently accepting new patients.

Expertise in
15
conditions
Dr. Nicholas K. Foreman
Hematology | Oncology
Expertise in
15
conditions
Dr. Nicholas K. Foreman
Hematology | Oncology
Referral may be required

Children's Hospital Colorado

1811 Plaza Dr, 
Highlands Ranch, CO 
 (15.8 miles away)
720-478-9840
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Nicholas Foreman is a Hematologist and an Oncologist practicing medicine in Highlands Ranch, Colorado. Dr. Foreman is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Ependymoma, Brain Tumor, Medulloblastoma, and Ganglioglioma. Dr. Foreman is currently accepting new patients.

Expertise in
8
conditions
Dr. Marilyn J. Manco-Johnson
Hematology | Oncology
Expertise in
8
conditions
Dr. Marilyn J. Manco-Johnson
Hematology | Oncology
Referral may be required

Children's Hospital Colorado

13123 E 16th Ave, 
Aurora, CO 
 (0.1 miles away)
720-777-1234
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Marilyn Manco-Johnson is a Hematologist and an Oncologist practicing medicine in Aurora, Colorado. Dr. Manco-Johnson is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Blood Clots, Hemophilia A, Mesenteric Venous Thrombosis, Hemophilia B, and Thrombectomy. Dr. Manco-Johnson is currently accepting new patients.

Frequently Asked Questions about Dr. Taizo A. Nakano

How do I make an appointment with Dr. Taizo A. Nakano?

You can book an appointment with Dr. Taizo A. Nakano by calling their office at 720-777-1234. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Taizo A. Nakano a top-rated expert for Aplastic Anemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Taizo A. Nakano is classified as an Distinguished expert for Aplastic Anemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Taizo A. Nakano specialize in?

While Dr. Taizo A. Nakano is a Hematology, they have specific expertise in Aplastic Anemia, Shwachman-Diamond Syndrome, and Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Taizo A. Nakano participate in research or clinical trials?

Yes. Dr. Taizo A. Nakano has published 46 articles and abstracts on conditions like Aplastic Anemia. You can view a list of Dr. Taizo A. Nakano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Taizo A. Nakano accept my insurance?

Dr. Taizo A. Nakano accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 720-777-1234 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nakano's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 26 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile